Researcher
Peter Van Dam
- Research Expertise:Translational investigations in breat and cervical cancer Immune environment in inflammatory breast cancer and cervical cancer Effect of Denosumab on the immune environment of cervical cancer Quality control of cancer treatment Telemonitoring of sidde effects of cancer treatment Cognitive impairment after cancer treatment
- Keywords:T CYTOTOXIC LYMPHOCYTE, T HELPER LYMPHOCYTE, Medicine
- Disciplines:Cancer biology, Cancer diagnosis, Cancer therapy
- Research techniques:Immunohistochemical staining Flow cytometry RNA seq
- Users of research expertise:Other interested groups
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Jan 2019 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Member
From1 Feb 2014 → 31 Dec 2018
Projects
1 - 10 of 10
- Establishing patient-derived organoids to rationally design therapies for patients with inflammatory breast cancerFrom1 Nov 2023 → TodayFunding: Nonprofit institution or equivalents
- Reinvigorating the antitumor immunity in human breastand cervical cancer with an innovative RANK(L) targeted combination strategy.From1 Nov 2021 → TodayFunding: Nonprofit institution or equivalents
- Development and validation of a novel rationally designed immunotherapeutic combination strategy built upon targeting RANK(L) for cervical cancer.From1 Nov 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Acquired immunity and immunologic aspects of SARS-CoV-2 infection a population of patients and healthcare workers in Multidisciplinary Oncologic Centres. (MOCOR-Study).From1 Jun 2020 → 31 May 2021Funding: BOF - projects
- Unveiling the drug repurposing versatility of denosumab in the battle against human cervical cancer.From1 Jan 2020 → 31 Dec 2020Funding: Nonprofit institution or equivalents
- Integrated Personalized & Precision Oncology Network (IPPON).From1 Jan 2020 → TodayFunding: BOF - research organisations, Fund Recuperation Fiscal Exemption
- The role of infiltrating immune cells in the aggresive phenotype of inflammatory breast cancer and possible new (immuno)therapeutic targets.From1 Oct 2018 → 30 Sep 2020Funding: FWO fellowships
- RANK signaling and checkpoint inhibition.From15 Sep 2018 → 14 Sep 2021Funding: Nonprofit institution or equivalents
- The role of infiltrating immune cells in the aggresive phenotype of inflammatory breast cancer and possible new (immuno)therapeutic targets.From1 Oct 2016 → 30 Sep 2018Funding: FWO fellowships
- Characterization of the stromal component in inflammatory breast cancer.From15 Jan 2016 → 14 Jan 2017Funding: Nonprofit institution or equivalents
Publications
41 - 50 of 108
- Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: results of an online survey(2020)
Authors: Annemie Luyckx, Leen Wyckmans, Anne-Sophie Bonte, Xuan Bich Trinh, Peter Van Dam
- AMTRA: a multicentered experience of a web-based monitoring and tailored toxicity management system for cancer patients(2020)
Authors: Marika Rasschaert, Christof Vulsteke, Sven De Keersmaeker, Kathleen Vandenborne, Stefanie Dias, Vincent Verschaeve, Peter Vuylsteke, Ilse Van Brussel, Jo Ravelingien, Peter Van Dam, et al.
Pages: 1 - 9 - A video-game based cognitive training for breast cancer survivors with cognitive impairment(2020)
Authors: Anne Bellens, Ella Roelant, Marc Peeters, Peter Van Dam
Pages: 23 - 32 - High mortality of cancer patients in times of SARS-CoV-2(2020)
Authors: Peter Van Dam, Manon Huizing, Kostantinos Papadimitriou, Hans Prenen, Marc Peeters
Pages: 225 - 227 - The art of obtaining a high yield of cell-free DNA from urine(2020)
Authors: Elien Augustus, Kaat Van Casteren, Laure Sorber, Peter Van Dam, Geert Roeyen, Marc Peeters, Alex Vorsters, An Wouters, Christian Rolfo, Karen Zwaenepoel, et al.
- The immunologic aspects in hormone receptor positive breast cancer(2020)
Authors: Gizem Oner, Sevilay Altintas, Zafer Canturk, Wiebren Tjalma, Christophe Van Berckelaer, Karen Zwaenepoel, Maria Tholhuijsen, Yannick Verhoeven, Zwi Berneman, Marc Peeters, et al.
- Oncological outcome, postoperative complications, and mammographic changes after intraoperative radiotherapy with electrons (IOERT) as a boost in a large single‐institution cohort of breast cancer patients(2020)
Authors: Melanie Machiels, Reinhilde Weytjens, Katrien Erven, Jasmijn M. Westerhoff, Souad Amrouch, Jana Bosiers, Luc Verkinderen, Jan Hauspy, Peter Van Dam, Piet Stevens, et al.
Pages: 1937 - 1945 - No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study(2020)
Authors: Jorne Ubachs, Simone N. Koole, Max Lahaye, Cristina Fabris, Leigh Bruijs, Jules Schagen van Leeuwen, Henk W.R. Schreuder, R.H. Hermans, I.H. de Hingh, J. van der Velden, et al.
Pages: 706 - 711 - SARS-CoV-2 and cancer(2020)
Authors: Peter Van Dam, Manon Huizing, Gino Mestach, Stazie Dierckxsens, Wiebren Tjalma, Xuan Bich Trinh, Kostantinos Papadimitriou, Sevilay Altintas, Jan Vermorken, Christof Vulsteke, et al.
- The potential and controversy of targeting STAT family members in cancer(2020)
Authors: Yannick Verhoeven, Sam Tilborghs, Julie Jacobs, Jorrit De Waele, Delphine Quatannens, Christophe Deben, Hans Prenen, Patrick Pauwels, Xuan Bich Trinh, An Wouters, et al.
Pages: 41 - 56